CASUS vs. APACHE II in Predicting Mortality After Coronary Artery Bypass Grafting (CASUS)

The Value of CASUS vs. APACHE II in Predicting Mortality Among Patients Undergoing Coronary Artery Bypass Grafting

The study seeks to determine the value of CASUS in predicting mortality as compared with APACHE II scoring system among patients undergoing coronary artery bypass grafting.

Study Overview

• Status: Completed
• Conditions: Mortality; Coronary Artery Bypass Grafting
• Intervention / Treatment: Other: Cardiac surgery score and APACHE II scoring

Detailed Description

Patients undergoing coronary artery bypass grafting will prospectively studied after the admission to the cardiac intensive care unit. Data on the preoperative condition, intraoperative parameters, and postoperative course will collected. CASUS and APACHE II scores will calculated on the first postoperative day. Clinical outcomes are defined as 7-day mortality, 30-day mortality and morbidity. Morbidity includes variables such as length of stay in the cardiac surgical intensive care unit and in the hospital.

• Study Type: Observational
• Enrollment (Actual): 204

Contacts and Locations

Study Locations

• Turkey
  • Istanbul, Turkey
    • Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
  • Istanbul, Turkey
    • Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital in Turkey

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

Study population includes all adult patients who undergoing coronary artery bypass grafting during the study period.

Description

Inclusion Criteria:

• Undergoing coronary artery bypass grafting
• Over 18 years of age
• Staying at least 24 hours in the cardiac intensive care unit

Exclusion Criteria:

• Emergency surgery

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Mortality at 7 days	Mortality in the first 7 days after surgery	7 days
Mortality at 30 days	Mortality in the first 30 days after surgery	30 days

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Length of stay in the cardiac intensive care unit	Only the length of the initial stay in the cardiac intensive care unit up to 3 months	Up to 3 months (Through study completion)
Length of the stay in the hospital	It includes the period from surgery to discharge	Up to 3 months (Through study completion)

Collaborators and Investigators

• Sponsor: Antalya Training and Research Hospital
• Collaborators: Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital; Haydarpasa Numune Training and Research Hospital
• Investigators: Study Director: Nihan YAPICI, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery TRH; Principal Investigator: Sümeyye UĞUR, Haydarpasa Numune Training and Research Hospital

Study record dates

Study Major Dates

• Study Start (Actual): January 2, 2019
• Primary Completion (Actual): March 10, 2019
• Study Completion (Actual): April 10, 2019

Study Registration Dates

• First Submitted: January 23, 2019
• First Submitted That Met QC Criteria: August 23, 2021
• First Posted (Actual): August 30, 2021

Study Record Updates

• Last Update Posted (Actual): August 30, 2021
• Last Update Submitted That Met QC Criteria: August 23, 2021
• Last Verified: August 1, 2021

More Information

Terms related to this study

• Keywords: cardiac surgery score, mortality, ICU
• Other Study ID Numbers: SU2019

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No